These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 8444849

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A screening procedure to evaluate the anticoagulant activity and the kinetic behaviour of direct thrombin inhibitors.
    Rupin A, Mennecier P, de Nanteuil G, Laubie M, Verbeuren TJ.
    Thromb Res; 1995 May 01; 78(3):217-25. PubMed ID: 7631302
    [Abstract] [Full Text] [Related]

  • 23. Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors.
    Gandossi E, Lunven C, Gauffeny C, Roome NO, Berry CN.
    Thromb Haemost; 1998 Nov 01; 80(5):840-4. PubMed ID: 9843181
    [Abstract] [Full Text] [Related]

  • 24. Synthetic selective inhibitors of coagulation factor Xa strongly inhibit thrombin generation without affecting initial thrombin forming time necessary for platelet activation in hemostasis.
    Ieko M, Tarumi T, Takeda M, Naito S, Nakabayashi T, Koike T.
    J Thromb Haemost; 2004 Apr 01; 2(4):612-8. PubMed ID: 15102016
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
    Wong PC, Jiang X.
    Thromb Haemost; 2010 Aug 01; 104(2):302-10. PubMed ID: 20589316
    [Abstract] [Full Text] [Related]

  • 27. Platelet deposition induced by severely damaged vessel wall is inhibited by a boroarginine synthetic peptide with antithrombin activity.
    Badimon JJ, Weng D, Chesebro JH, Fuster V, Badimon L.
    Thromb Haemost; 1994 Apr 01; 71(4):511-6. PubMed ID: 8052972
    [Abstract] [Full Text] [Related]

  • 28. In vitro and in vivo properties of bicyclic lactam inhibitors: a novel class of low molecular weight peptidomimetic thrombin inhibitors.
    Leblond L, Grouix B, Boudreau C, Yang Q, Siddiqui MA, Winocour PD.
    Thromb Res; 2000 Nov 01; 100(3):195-209. PubMed ID: 11108907
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Platelet activation with unfractionated heparin at therapeutic concentrations and comparison with low-molecular-weight heparin and with a direct thrombin inhibitor.
    Cella G, Girolami A, Sasahara AA.
    Circulation; 1999 Jun 29; 99(25):3323. PubMed ID: 10385510
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. In vitro effects of inogatran, a selective low molecular weight thrombin inhibitor.
    Teger-Nilsson AC, Bylund R, Gustafsson D, Gyzander E, Eriksson U.
    Thromb Res; 1997 Jan 15; 85(2):133-45. PubMed ID: 9058487
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Peptide-derived transition state analogue inhibitors of thrombin; synthesis, activity and selectivity.
    Jetten M, Peters CA, Visser A, Grootenhuis PD, van Nispen JW, Ottenheijm HC.
    Bioorg Med Chem; 1995 Aug 15; 3(8):1099-114. PubMed ID: 7582983
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Inhibition of factor Xa-induced platelet aggregation by a selective thrombin inhibitor, argatroban.
    Kawai H, Yamamoto T, Hara H, Tamao Y.
    Thromb Res; 1994 May 01; 74(3):185-91. PubMed ID: 8042187
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.